Lisa DeFrancesco | Vice President, Investor Relations |
Mark Pruzanski | Chief Executive Officer |
Jerry Durso | Chief Operating Officer |
Sandip Kapadia | Chief Financial Officer |
Emma Nealon | Cantor Fitzgerald |
Brian Abrahams | RBC Capital Markets |
Michael Yee | Jefferies |
Ritu Baral | Cowen |
Yasmeen Rahimi | Roth Capital Partners |
Jay Olson | Oppenheimer |
Ross Weinreb | Goldman Sachs |
Jack Allen | Baird |
Steve Seedhouse | Raymond James |
Alan Carr | Needham |
Liisa Bayko | JMP Securities |
Joel Beatty | Citi |
Jim Birchenough | Wells Fargo |
Navin Jacob | UBS |
Good morning, ladies and gentlemen, and thank you for joining the Intercept Pharmaceuticals Third Quarter 2019 Financial Results Conference Call. All participants are now in the listen-only mode.
Following opening remarks, Intercept’s management will open the lines for a question-and-answer period. Please be advised that this call is being recorded at the company's request and a webcast of this call will be archived on the company's website for approximately two weeks.
I would now like to introduce Lisa DeFrancesco, Vice President, Investor Relations.